Justices Want Natera’s Take On CareDx’s False Ad Petition

By Editorial Team

The U.S. Supreme Court has requested Natera’s position on a petition from rival CareDx seeking a review of a Third Circuit decision that nullified a $45 million jury award related to CareDx’s false advertising claims.

CareDx has petitioned the high court to reconsider the Third Circuit’s decision that overturned the jury award. The case revolves around allegations of false advertising made by CareDx against Natera.

The Supreme Court’s interest in Natera’s perspective suggests that the Court is considering whether to grant review of the case. Natera’s response could influence the Court’s decision on whether to take up the matter.

Both Natera and CareDx are prominent players in the healthcare industry, particularly in the field of genetic testing and diagnostics. The outcome of this legal battle could have significant implications for the competitive landscape within the industry.

Legal experts are closely monitoring the developments in this case, as it could set important precedents in the realm of false advertising claims and intellectual property disputes.

For more updates on this case and other legal news, subscribe to Law360 for comprehensive coverage and analysis of key legal developments.